Olympus Corp
TSE:7733
Olympus Corp
Operating Income
Olympus Corp
Operating Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Olympus Corp
TSE:7733
|
Operating Income
¥137.9B
|
CAGR 3-Years
4%
|
CAGR 5-Years
8%
|
CAGR 10-Years
5%
|
|
|
Terumo Corp
TSE:4543
|
Operating Income
¥168.1B
|
CAGR 3-Years
13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
9%
|
|
|
Sysmex Corp
TSE:6869
|
Operating Income
¥91.5B
|
CAGR 3-Years
13%
|
CAGR 5-Years
9%
|
CAGR 10-Years
8%
|
|
|
Nihon Kohden Corp
TSE:6849
|
Operating Income
¥20B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
3%
|
CAGR 10-Years
1%
|
|
|
JEOL Ltd
TSE:6951
|
Operating Income
¥40.6B
|
CAGR 3-Years
56%
|
CAGR 5-Years
41%
|
CAGR 10-Years
23%
|
|
|
Fukuda Denshi Co Ltd
TSE:6960
|
Operating Income
¥24.6B
|
CAGR 3-Years
1%
|
CAGR 5-Years
13%
|
CAGR 10-Years
9%
|
|
Olympus Corp
Glance View
Olympus Corporation, originating from the heart of Japan in 1919, has evolved into a global powerhouse, particularly revered for its contributions to the field of optics and imaging. Initially carving its reputation through crafting precision microscope lenses, Olympus seamlessly expanded its capabilities into the realms of endoscopy and digital imaging. This strategic pivot not only defined its legacy but firmly anchored its presence in the medical world, where it became a leader in endoscopic technology. The company adeptly leveraged its expertise to revolutionize medical diagnostics and treatment, helping medical professionals see and diagnose better—enhancing both physician dexterity and patient outcomes. Revenue for Olympus is predominantly driven by its Medical Business sector, which constitutes a significant portion of its overall profits, underscoring its transformation from a diversified manufacturer to a specialized player in healthcare technology. They are deeply committed to R&D, funneling substantial resources to innovate and bolster their portfolio in medical devices, particularly in fields like therapeutic interventions. While imaging products for consumers have historically been a notable segment, the shift toward medical technology aligns with broader market demands and ensures sustainable growth. This focus demonstrates Olympus's intent to maximize its competitive advantages, allowing it to remain at the forefront of its niche industries and effectively respond to global healthcare challenges.
See Also
What is Olympus Corp's Operating Income?
Operating Income
137.9B
JPY
Based on the financial report for Dec 31, 2024, Olympus Corp's Operating Income amounts to 137.9B JPY.
What is Olympus Corp's Operating Income growth rate?
Operating Income CAGR 10Y
5%
Over the last year, the Operating Income growth was 53%. The average annual Operating Income growth rates for Olympus Corp have been 4% over the past three years , 8% over the past five years , and 5% over the past ten years .
You don't have any saved screeners yet